Postpartum Vaccines and Contraception Integration for Birth Control

(PIVoT Trial)

No longer recruiting at 1 trial location
GK
Overseen ByGennifer Kully, MSc
Age: 18+
Sex: Female
Trial Phase: Academic
Sponsor: University of California, San Diego
No Placebo GroupAll trial participants will receive the active study treatment (no placebo)

What You Need to Know Before You Apply

What is the purpose of this trial?

This trial explores a new method of combining family planning with infant vaccinations to help new mothers in rural areas access birth control more easily. The study will test whether providing family planning advice and contraception during baby vaccination visits improves postpartum contraceptive use. Mothers who recently had a baby within the last 12 weeks, speak Marathi, live in rural Maharashtra, and haven't undergone certain medical procedures like sterilization or immediate post-birth IUD placement may qualify for this trial. As an unphased trial, this study offers a unique opportunity to contribute to innovative healthcare solutions for new mothers in rural communities.

Do I have to stop taking my current medications for this trial?

The trial protocol does not specify whether you need to stop taking your current medications.

What prior data suggests that this program is safe for postpartum women?

Research has shown that combining vaccines and birth control in postpartum care can be safe and effective. Successful methods empower women, helping them make informed choices about family planning. This approach has succeeded in communities without causing major side effects.

Although specific safety data for the PIVoT program is not available, similar methods have been well-received. These programs aim to remove obstacles and make family planning easier and more accessible, especially in resource-limited areas. This suggests that the PIVoT program is likely safe, as it builds on these proven methods.12345

Why are researchers excited about this trial?

Researchers are excited about the PIVoT approach because it integrates postpartum contraception with infant vaccination through gender-transformative family planning. Unlike the standard of care, which typically separates infant vaccination from family planning support, PIVoT combines these crucial services at a single point. This integration can potentially improve access to contraception for new mothers, making it easier and more convenient for them to manage family planning. By using this combined approach, PIVoT aims to empower women with more immediate and practical options for birth control, which could lead to better health outcomes for both mothers and their infants.

What evidence suggests that the Postpartum Integration of Vaccines and Contraception Through Gender-Transformative Programming (PIVoT) is effective for postpartum contraceptive use?

This trial will compare the PIVoT approach with standard care. Studies have shown that combining family planning services with infant vaccination visits helps new mothers use birth control more effectively after giving birth. In this trial, the PIVoT approach offers family planning advice during regular baby vaccine appointments. Research indicates that this method can overcome gender-related barriers, making it easier for women to accept and use contraceptives after childbirth. Successful pilot programs have demonstrated that this integration helps more women in low-resource areas access and use birth control. By offering these services together, PIVoT aims to provide a smooth and effective way to support new mothers in planning their families.13678

Who Is on the Research Team?

SA

Sarah Averbach, MD, MAS

Principal Investigator

University of California, San Diego

SB

Shahina Begum, PhD

Principal Investigator

Indian Council of Medical Research-National Institute for Research in Reproductive and Child Health

Are You a Good Fit for This Trial?

This trial is for postpartum women who speak Marathi, delivered a baby within the last 8 weeks, live in rural Maharashtra, and have not had sterilization or certain immediate post-birth contraceptive procedures. Pregnant women cannot participate.

Inclusion Criteria

Postpartum women who delivered a baby within the past 12 weeks
Reside in rural Maharashtra
Did not undergo sterilization, hysterectomy or immediate postpartum intrauterine device (IUD) placement
See 1 more

Exclusion Criteria

Currently pregnant

Timeline for a Trial Participant

Screening

Participants are screened for eligibility to participate in the trial

2-4 weeks

Intervention

Participants receive gender-transformative family planning counseling and contraception provision at the time of infant vaccination

6 weeks
Monthly visits at Village Health and Nutrition Days

Follow-up

Participants are monitored for contraceptive use and intervention feasibility, acceptability, and appropriateness

12 months
Follow-up at 6 months and 12 months postpartum

Qualitative Evaluation

In-depth interviews with participants, their husbands, and health care providers to evaluate the intervention

Post-study completion

What Are the Treatments Tested in This Trial?

Interventions

  • Postpartum Integration of Vaccines and Contraception Through Gender-Transformative Programming(PIVoT)
Trial Overview The study tests a program that combines family planning with infant vaccination services to see if it increases birth control use after childbirth in rural areas. It's focused on changing gender norms to improve health outcomes.
How Is the Trial Designed?
2Treatment groups
Experimental Treatment
Active Control
Group I: PIVoTExperimental Treatment1 Intervention
Group II: Standard of careActive Control1 Intervention

Find a Clinic Near You

Who Is Running the Clinical Trial?

University of California, San Diego

Lead Sponsor

Trials
1,215
Recruited
1,593,000+

Indian Council of Medical Research

Collaborator

Trials
71
Recruited
137,000+

Published Research Related to This Trial

A significant number of pregnant and postpartum women (over 40%) expressed a desire to change their contraceptive method after delivery, highlighting the need for tailored contraceptive counseling during this period.
Reliability, efficacy, and safety during breastfeeding were identified as key attributes for contraception, with many women feeling dissatisfied with their previous methods, especially those with unplanned pregnancies.
Peripartum contraceptive attitudes and practices.Cwiak, C., Gellasch, T., Zieman, M.[2007]
Educational interventions for postpartum women can improve contraceptive use, particularly when initiated immediately after delivery, as seen in a study from Nepal where women who received early education were more likely to use contraception at six months (OR 1.62).
Home-based mentoring programs for adolescents showed a significant reduction in repeat pregnancies, with a study indicating fewer second births within two years compared to controls (OR 0.41), highlighting the potential effectiveness of tailored support in this demographic.
Education for contraceptive use by women after childbirth.Lopez, LM., Grey, TW., Hiller, JE., et al.[2020]
Postpartum women have a wide range of contraceptive options, but their choice may be influenced by whether they are breastfeeding and the natural recovery process after childbirth.
There is ongoing debate about the safety of using oral contraceptives while breastfeeding, particularly regarding how hormonal contraceptives might affect lactation and infant health, highlighting the importance of informed counseling for new mothers.
Contraception for the postpartum woman.Sweezy, SR.[2005]

Citations

Postpartum Integration of Vaccines and Contraception TrialThis study aims to examine how to implement a gender-transformative post-partum family planning program integrated into community-based infant vaccination ...
RePORT RePORTER - National Institutes of Health (NIH) |The objective of this study is to pilot test PIVoT (Postpartum Integration of Vaccines and contraception through gender-Transformative programming), delivered ...
Postpartum Vaccines and Contraception Integration for ...This study aims to examine how to implement a gender-transformative post-partum family planning program integrated into community-based infant vaccination ...
Grant R21HD108351 San Diego University Of CaliforniaThe objective of this study is to pilot test PIVOT (Postpartum Integration of Vaccines and Contraception through Gender-Transformative Programming), delivered ...
Successful strategies that address gender-related barriers ...They achieved this through quality improvement strat- egies that seamlessly integrated contraception services into the continuum of postpartum and postabortion.
Postpartum Integration of Vaccines and Contraception Trial ...This study aims to examine how to implement a gender-transformative post-partum family planning program integrated into community-based infant ...
Successful strategies that address gender-related barriers ...The gender-transformative strategies reported in the studies shared a commitment to empowering women with the autonomy to make informed ...
Family Planning and Immunization IntegrationThis HIP Brief focuses on integration of family planning with immunization during the extended postpartum period, which is the one-year period after delivery.
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Terms of Service·Privacy Policy·Cookies·Security